Cargando…
MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data
[Image: see text] In the rapidly moving proteomics field, a diverse patchwork of data analysis pipelines and algorithms for data normalization and differential expression analysis is used by the community. We generated a mass spectrometry downstream analysis pipeline (MS-DAP) that integrates both po...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903323/ https://www.ncbi.nlm.nih.gov/pubmed/36541440 http://dx.doi.org/10.1021/acs.jproteome.2c00513 |
_version_ | 1784883448753684480 |
---|---|
author | Koopmans, Frank Li, Ka Wan Klaassen, Remco V. Smit, August B. |
author_facet | Koopmans, Frank Li, Ka Wan Klaassen, Remco V. Smit, August B. |
author_sort | Koopmans, Frank |
collection | PubMed |
description | [Image: see text] In the rapidly moving proteomics field, a diverse patchwork of data analysis pipelines and algorithms for data normalization and differential expression analysis is used by the community. We generated a mass spectrometry downstream analysis pipeline (MS-DAP) that integrates both popular and recently developed algorithms for normalization and statistical analyses. Additional algorithms can be easily added in the future as plugins. MS-DAP is open-source and facilitates transparent and reproducible proteome science by generating extensive data visualizations and quality reporting, provided as standardized PDF reports. Second, we performed a systematic evaluation of methods for normalization and statistical analysis on a large variety of data sets, including additional data generated in this study, which revealed key differences. Commonly used approaches for differential testing based on moderated t-statistics were consistently outperformed by more recent statistical models, all integrated in MS-DAP. Third, we introduced a novel normalization algorithm that rescues deficiencies observed in commonly used normalization methods. Finally, we used the MS-DAP platform to reanalyze a recently published large-scale proteomics data set of CSF from AD patients. This revealed increased sensitivity, resulting in additional significant target proteins which improved overlap with results reported in related studies and includes a large set of new potential AD biomarkers in addition to previously reported. |
format | Online Article Text |
id | pubmed-9903323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99033232023-02-08 MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data Koopmans, Frank Li, Ka Wan Klaassen, Remco V. Smit, August B. J Proteome Res [Image: see text] In the rapidly moving proteomics field, a diverse patchwork of data analysis pipelines and algorithms for data normalization and differential expression analysis is used by the community. We generated a mass spectrometry downstream analysis pipeline (MS-DAP) that integrates both popular and recently developed algorithms for normalization and statistical analyses. Additional algorithms can be easily added in the future as plugins. MS-DAP is open-source and facilitates transparent and reproducible proteome science by generating extensive data visualizations and quality reporting, provided as standardized PDF reports. Second, we performed a systematic evaluation of methods for normalization and statistical analysis on a large variety of data sets, including additional data generated in this study, which revealed key differences. Commonly used approaches for differential testing based on moderated t-statistics were consistently outperformed by more recent statistical models, all integrated in MS-DAP. Third, we introduced a novel normalization algorithm that rescues deficiencies observed in commonly used normalization methods. Finally, we used the MS-DAP platform to reanalyze a recently published large-scale proteomics data set of CSF from AD patients. This revealed increased sensitivity, resulting in additional significant target proteins which improved overlap with results reported in related studies and includes a large set of new potential AD biomarkers in addition to previously reported. American Chemical Society 2022-12-21 /pmc/articles/PMC9903323/ /pubmed/36541440 http://dx.doi.org/10.1021/acs.jproteome.2c00513 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Koopmans, Frank Li, Ka Wan Klaassen, Remco V. Smit, August B. MS-DAP Platform for Downstream Data Analysis of Label-Free Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased Sensitivity in Analysis of Alzheimer’s Biomarker Data |
title | MS-DAP Platform
for Downstream Data Analysis of Label-Free
Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased
Sensitivity in Analysis of Alzheimer’s Biomarker Data |
title_full | MS-DAP Platform
for Downstream Data Analysis of Label-Free
Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased
Sensitivity in Analysis of Alzheimer’s Biomarker Data |
title_fullStr | MS-DAP Platform
for Downstream Data Analysis of Label-Free
Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased
Sensitivity in Analysis of Alzheimer’s Biomarker Data |
title_full_unstemmed | MS-DAP Platform
for Downstream Data Analysis of Label-Free
Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased
Sensitivity in Analysis of Alzheimer’s Biomarker Data |
title_short | MS-DAP Platform
for Downstream Data Analysis of Label-Free
Proteomics Uncovers Optimal Workflows in Benchmark Data Sets and Increased
Sensitivity in Analysis of Alzheimer’s Biomarker Data |
title_sort | ms-dap platform
for downstream data analysis of label-free
proteomics uncovers optimal workflows in benchmark data sets and increased
sensitivity in analysis of alzheimer’s biomarker data |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903323/ https://www.ncbi.nlm.nih.gov/pubmed/36541440 http://dx.doi.org/10.1021/acs.jproteome.2c00513 |
work_keys_str_mv | AT koopmansfrank msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata AT likawan msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata AT klaassenremcov msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata AT smitaugustb msdapplatformfordownstreamdataanalysisoflabelfreeproteomicsuncoversoptimalworkflowsinbenchmarkdatasetsandincreasedsensitivityinanalysisofalzheimersbiomarkerdata |